CVS Health Corporation Financial Statements (CVS)
|
|
|
|
Report date
|
|
|
18.02.2020 |
16.02.2021 |
09.02.2022 |
08.02.2023 |
07.02.2024 |
|
06.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
256 776 |
268 706 |
292 111 |
321 629 |
357 776 |
|
368 280 |
|
Operating Income, bln rub |
|
|
11 987 |
13 911 |
13 193 |
15 742 |
13 743 |
|
9 384 |
|
EBITDA, bln rub |
? |
|
16 348 |
17 083 |
17 401 |
12 332 |
18 178 |
|
14 178 |
|
Net profit, bln rub |
? |
|
6 634 |
7 179 |
8 001 |
4 311 |
8 344 |
|
5 016 |
|
|
OCF, bln rub |
? |
|
12 848 |
15 865 |
18 265 |
16 177 |
13 426 |
|
4 611 |
|
CAPEX, bln rub |
? |
|
2 457 |
2 437 |
2 520 |
2 727 |
3 031 |
|
2 924 |
|
FCF, bln rub |
? |
|
10 391 |
13 428 |
15 745 |
13 450 |
10 395 |
|
1 687 |
|
Dividend payout, bln rub
|
|
|
2 603 |
2 624 |
2 625 |
2 907 |
3 132 |
|
3 314 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
39.2% |
36.6% |
32.8% |
67.4% |
37.5% |
|
66.1% |
|
|
OPEX, bln rub |
|
|
33 541 |
35 135 |
37 066 |
46 379 |
40 688 |
|
41 498 |
|
Cost of production, bln rub |
|
|
211 248 |
219 660 |
240 063 |
267 965 |
303 345 |
|
316 534 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
3 035 |
2 907 |
2 503 |
2 287 |
2 658 |
|
2 890 |
|
|
Assets, bln rub |
|
|
222 449 |
230 715 |
232 999 |
228 275 |
249 728 |
|
252 427 |
|
Net Assets, bln rub |
? |
|
63 864 |
69 389 |
75 075 |
71 015 |
76 461 |
|
74 944 |
|
Debt, bln rub |
|
|
89 002 |
85 042 |
75 999 |
70 732 |
79 385 |
|
82 704 |
|
Cash, bln rub |
|
|
8 056 |
10 854 |
12 525 |
15 723 |
11 455 |
|
6 875 |
|
Net debt, bln rub |
|
|
80 946 |
74 188 |
63 474 |
55 009 |
67 930 |
|
75 829 |
|
|
Ordinary share price, rub |
|
|
74.3 |
68.3 |
103.2 |
93.2 |
79.0 |
|
69.7 |
|
Number of ordinary shares, mln |
|
|
1 301 |
1 309 |
1 319 |
1 312 |
1 285 |
|
1 259 |
|
|
Market cap, bln rub |
|
|
96 651 |
89 405 |
136 068 |
122 265 |
101 464 |
|
87 715 |
|
EV, bln rub |
? |
|
177 597 |
163 593 |
199 542 |
177 274 |
169 394 |
|
163 544 |
|
Book value, bln rub |
|
|
-49 006 |
-41 305 |
-33 072 |
-31 889 |
-44 045 |
|
-44 145 |
|
|
EPS, rub |
? |
|
5.10 |
5.48 |
6.07 |
3.29 |
6.49 |
|
3.98 |
|
FCF/share, rub |
|
|
7.99 |
10.3 |
11.9 |
10.3 |
8.09 |
|
1.34 |
|
BV/share, rub |
|
|
-37.7 |
-31.6 |
-25.1 |
-24.3 |
-34.3 |
|
-35.1 |
|
|
EBITDA margin, % |
? |
|
6.37% |
6.36% |
5.96% |
3.83% |
5.08% |
|
3.85% |
|
Net margin, % |
? |
|
2.58% |
2.67% |
2.74% |
1.34% |
2.33% |
|
1.36% |
|
FCF yield, % |
? |
|
10.8% |
15.0% |
11.6% |
11.0% |
10.2% |
|
1.92% |
|
ROE, % |
? |
|
10.4% |
10.3% |
10.7% |
6.07% |
10.9% |
|
6.69% |
|
ROA, % |
? |
|
2.98% |
3.11% |
3.43% |
1.89% |
3.34% |
|
1.99% |
|
|
P/E |
? |
|
14.6 |
12.5 |
17.0 |
28.4 |
12.2 |
|
17.5 |
|
P/FCF |
|
|
9.30 |
6.66 |
8.64 |
9.09 |
9.76 |
|
52.0 |
|
P/S |
? |
|
0.38 |
0.33 |
0.47 |
0.38 |
0.28 |
|
0.24 |
|
P/BV |
? |
|
-1.97 |
-2.16 |
-4.11 |
-3.83 |
-2.30 |
|
-1.99 |
|
EV/EBITDA |
? |
|
10.9 |
9.58 |
11.5 |
14.4 |
9.32 |
|
11.5 |
|
Debt/EBITDA |
|
|
4.95 |
4.34 |
3.65 |
4.46 |
3.74 |
|
5.35 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.96% |
0.91% |
0.86% |
0.85% |
0.85% |
|
0.79% |
|
| CVS Health Corporation shareholders |
